In summary, PARPi leads to the amplification of STING signaling; upregulation of interferons and chemoattractants; the repertoire of tumor antigens; TMB; T cell activation and recruitment; and the expression of immune blockade targets, like PD-L1 [38,68,69]. Here, CD274 is linked to neoplasm.